- mDR published responses to SIAS questions ahead of its shareholder meeting, focused on a renounceable, non-underwritten rights cum warrants issue of five rights shares for every three existing shares, with one warrant for every one rights share subscribed.
- On multiple revisions since the initial announcement, the company said it adjusted terms after market feedback, citing higher share price and trading volume, and said it revised pricing and warrant mechanics to balance fund-raising size with an acceptable discount.
- On whether regulators or shareholders raised dilution concerns, mDR said it shared its pricing rationale with the regulator and that the company itself proposed the revisions based on investor feedback reflected in market activity.
- On who proposed the structure and how fairness was assessed, the company said management proposed the rights issue and the board emphasized that renounceable rights allow shareholders to sell nil-paid rights to avoid economic loss other than transaction costs.
- On allocation of excess rights and warrants, mDR said directors will decide the method after the closing date, with preference for rounding odd lots and with directors and substantial shareholders ranking last for odd-lot rounding and excess allocation.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. mDR Limited published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: HUMH9KRB0NUVCV5M) on March 25, 2026, and is solely responsible for the information contained therein.
Comments